| 1 |
周玲凤，何庆华，唐海，等. 慢性阻塞性肺疾病流行病学调查及防控分析[J]. 中国医学创新，2021, 18(6): 84-87.
|
| 2 |
Raghavan S, Hatipoglu U, Aboussouan LS. Goals of chronic obstructive pulmonary disease management: a focused review for clinicians[J]. Curr Opin Pulm Med, 2025, 31(2): 156-164.
|
| 3 |
Alupo P, Baluku J, Bongomin F, et al. Overcoming challenges of managing chronic obstructive pulmonary disease in low-and middle-income countries[J]. Expert Rev Respir Med, 2024, 18(11): 873-882.
|
| 4 |
Christenson SA, Smith BM, Bafadhel M, et al. Chronic obstructive pulmonary disease[J]. Lancet, 2022, 399(10342): 2227-2242.
|
| 5 |
Qian Y, Cai C, Sun M, et al. Analyses of factors associated with acute exacerbations of chronic obstructive pulmonary disease: A review[J]. Int J Chron Obstruct Pulmon Dis, 2023, 18: 2707-2723.
|
| 6 |
刘莹芳，贾明月，肖锶瑶，等. 基于数据挖掘的国医大师晁恩祥教授治疗AECOPD的用药规律探究[J]. 中国医院用药评价与分析，2024, 24(10): 1225-1229.
|
| 7 |
张建军，马天翔，郭华荣，等. 基于数据挖掘技术对中医治疗慢性支气管炎用药规律的研究[J]. 光明中医，2022, 37(16): 2877-2879.
|
| 8 |
顾银花，顾敏亮，茅杰. 化痰止咳合剂治疗痰湿蕴肺型慢性支气管炎老年患者的临床观察[J]. 基层中医药，2025, 4(1): 32-36.
|
| 9 |
国家卫生健康委员会急诊医学质控中心，中华医学会急诊医学分会，中国医师协会急诊医师分会，等. 中国慢性阻塞性肺疾病急性加重中西医诊治专家共识(2021)[J]. 中华危重病急救医学，2021, 33(11): 1281-1290.
|
| 10 |
中华中医药学会内科分会肺系病专业委员会. 慢性阻塞性肺疾病中医诊疗指南(2011版)[J]. 中医杂志，2012, 53(1): 80-84.
|
| 11 |
沈凌．慢阻肺急性加重，如何选用抗菌药物——《慢性阻塞性肺疾病急性加重抗感染治疗中国专家共识》解读[J]. 医师在线，2020, 10(1): 18-19.
|
| 12 |
冯钰，曾晓丽，董理，等. 慢阻肺患者体质指数对肺功能的影响[J]. 中华健康管理学杂志，2022, 16(4): 229-235.
|
| 13 |
郭占敏，金小乐，杨博文，等. BUA、FIB联合RDW预测慢性阻塞性肺疾病急性发作风险的效能[J]. 临床误诊误治，2024, 37(1): 43-47.
|
| 14 |
钟萍，范贤明，蒋雪莲，等. COPD稳定期患者血清IL-6、IL-18、CC16水平与肺功能及CAT评分的关系[J]. 实用医学杂志，2016, 32(21): 3547-3551.
|
| 15 |
Kotlyarov S. Involvement of the innate immune system in the pathogenesis of chronic obstructive pulmonary disease[J]. Int J Mol Sci, 2022, 23(2): 985.
|
| 16 |
Kim GD, Lim EY, Shin HS. Macrophage polarization and functions in pathogenesis of chronic obstructive pulmonary disease[J]. Int J Mol Sci, 2024, 25(11): 5631.
|
| 17 |
Araya J, Kuwano K. Cellular senescence-an aging hallmark in chronic obstructive pulmonary disease pathogenesis[J]. Respir Investig, 2022, 60(1): 33-44.
|
| 18 |
Vij N, Chandramani-Shivalingappa P, Van Westphal C, et al. Cigarette smoke-induced autophagy impairment accelerates lung aging, COPD-emphysema exacerbations and pathogenesis[J]. Am J Physiol Cell Physiol, 2018, 314(1): C73-C87.
|
| 19 |
韩云侠，张虹. 益气健脾化痰祛湿法在慢性阻塞性肺疾病运用[J]. 内蒙古中医药，2018, 37(3): 34-35.
|
| 20 |
李竹英，郅扶旻，刘文波. 益气健脾化痰法对COPD稳定期患者肺功能及免疫功能的影响[J]. 中医药信息，2014, 31(1): 51-53.
|
| 21 |
Qian Y, Cai C, Sun M, et al. Analyses of Factors Associated with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Review[J]. Int J Chron Obstruct Pulmon Dis, 2023, 18: 2707-2723.
|
| 22 |
撰写组慢性阻塞性肺疾病免疫调节治疗专家共识. 慢性阻塞性肺疾病免疫调节治疗专家共识[J]. 中国全科医学，2022, 25(24): 2947-2959.
|
| 23 |
国家卫生健康委员会急诊医学质控中心，中华医学会急诊医学分会，中国医师协会急诊医师分会，等. 中国慢性阻塞性肺疾病急性加重中西医诊治专家共识(2021)[J]. 中华危重病急救医学，2021, 33(11): 1281-1290.
|
| 24 |
孔德昭，王科雯，罗文晔，等. 慢性阻塞性肺疾病急性加重期诊疗指南评价与综合分析[J]. 中国中医基础医学杂志，2023, 29(8): 1307-1317.
|
| 25 |
Christenson SA, Smith BM, Bafadhel M, et al. Chronic obstructive pulmonary disease[J]. Lancet, 2022, 399(10342): 2227-2242.
|
| 26 |
Ritchie AI, Donaldson GC, Hoffman EA, et al. Structural predictors of lung function decline in young smokers with normal spirometry[J]. Am J Respir Crit Care Med, 2024, 209(10): 1208-1218.
|
| 27 |
Zhu Y, Zhang Z, Du Z, et al. Mind-body exercise for patients with stable COPD on lung function and exercise capacity: a systematic review and meta-analysis of RCTs[J]. Sci Rep, 2024, 14(1): 18300.
|
| 28 |
施艳，黄容，魏琦. 二陈汤合三子养亲汤治疗痰湿蕴肺型COPD急性加重期的疗效观察[J]. 江西医药，2024, 59(7): 666-668.
|
| 29 |
Ruan H, Zhang H, Wang J, et al. Readmission rate for acute exacerbation of chronic obstructive pulmonary disease: A systematic review and meta-analysis[J]. Respir Med, 2023, 206: 107090.
|
| 30 |
Dong H, Hao Y, Li D, et al. Risk factors for acute exacerbation of chronic obstructive pulmonary disease in industrial regions of China: A multicenter cross-sectional study[J]. Int J Chron Obstruct Pulmon Dis, 2020, 15: 2249-2256.
|